Bio-Imaging of Colorectal Cancer Models Using Near Infrared Labeled Epidermal Growth Factor

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Cohen, Gadi ^a   Lecht, Shimon ^a   Arien Zakay, Hadar ^a   Ettinger, Keren ^a   Amsalem, Orit ^a   Oron Herman, Mor ^b   Yavin, Eylon ^a   Prus, Diana ^c   Benita, Simon ^a   Nissan, Aviram ^c   Lazarovici, Philip ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; SMALL INTERFERING RNA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CANCER CELL CULTURE; CANCER LOCALIZATION; CANCER MODEL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; MOLECULAR IMAGING; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO; STANDARDIZATION; WESTERN BLOTTING;

ADULT; ANIMALS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DIAGNOSTIC IMAGING; EPIDERMAL GROWTH FACTOR; HUMANS; MICE; MOLECULAR PROBE TECHNIQUES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; SIGNAL-TO-NOISE RATIO; TUMOR CELLS, CULTURED;

MUS;

EID: 84869033688     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048803     Document Type: Article

References (45)

1. Ramos M, Esteva M, Cabeza E, Campillo C, Llobera J, et al. (2007) Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer 43: 2467-2478.
2. Van Cutsem E, Nordlinger B, Cervantes A, (2010) Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment. Ann Oncol 21: 93-97.
3. Shawver LK, Slamon D, (2002) Ullrich (2002) A Smart drugs: tyrosine kinase inhibitors in cancer therapy. Cancer Cell 1: 117-123.
4. Arnold CN, Goel A, Blum HE, Boland CR, (2005) Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis. Cancer 104: 2035-2047.
5. Walsh JM, Terdiman JP, (2003) Colorectal cancer screening: scientific review. JAMA 289: 1288-1296.
6. Ho-Pun-Cheung A, Bascoul-Mollevi C, Assenat E, Boissière-Michot F, Bibeau F, et al. (2009) Reverse transcription-quantitative polymerase chain reaction: description of a RIN-based algorithm for accurate data normalization. BMC Mol Biol 10: 31.
7. Atkins D, Reiffen KA, Tegtmeier CL, Winther H, Bonato MS, et al. (2004) Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections. J Histochem Cytochem 52: 893-901.
8. Patel VG, Shum-Siu A, Heniford BW, Wieman TJ, Hendler FJ, (1994) Detection of epidermal growth factor receptor mRNA in tissue sections from biopsy specimens using in situ polymerase chain reaction. Am J Pathol 144: 7-14.
9. Jas P, López-Gómez M, Aguayo C, Madero R, Moreno-Rubio J, et al. (2012) Analysis of the concordance in the EGFR pathway status between primary tumors and relatedmetastases of colorectal cancer patients: implications for cancer therapy. Curr Cancer Drug Targets 12: 124-131.
10. Bianco R, Gelardi T, Damiano V, Ciardiello F, Tortora G (2007) Rational bases for the development of EGFR inhibitors for cancer treatment. Int J Biochem Cell Biol 39: 1416-1431.
11. Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, et al. (2008) K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 359: 1757-1765.
12. Bardelli A, Siena S, (2010) Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer. J Clin Oncol 28: 1254-1261.
13. Montagut C, Dalmases A, Bellosillo B, Crespo M, Pairet S, et al. (2012) Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer. Nat Med 18: 221-223.
14. Mishani E, Hagooly A, (2009) Strategies for molecular imaging of epidermal growth factor receptor tyrosine kinase in cancer. J Nucl Med 50: 1199-1202.
15. Gurfinkel M, Ke S, Wen X, Li C, Sevick-Muraca EM, (2003) Near-infrared fluorescence optical imaging and tomography. Dis Markers 19: 107-221.
16. Ke S, Wen X, Gurfinkel M, Charnsangavej C, Wallace S, et al. (2003) Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 63: 7870-7875.
17. Weissleder R, Pittet MJ, (2008) Imaging in the era of molecular oncology. Nature 452: 580-589.
18. Gong H, Kovar J, Little G, Chen H, Olive DM, (2010) In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore. Neoplasia 12: 139-149.
19. Losi L, Baisse B, Bouzourene H, Benhattar J, (2005) Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. Carcinogenesis 26: 916-922.
20. Brattain MG, Levine AE, Chakrabarty S, Yeoman LC, Willson JK, et al. (1984) Heterogeneity of human colon carcinoma. Cancer Metastasis Rev 3: 177-191.
21. Lisy MR, Goermar A, Thomas C, Pauli J, Resch-Genger U, et al. (2008) In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice. Radiology 247: 779-787.
22. Chen G, Kronenberger P, Teugels E, De Grève J, (2011) Influence of RT-qPCR primer position on EGFR interference efficacy in lung cancer cells. Biol Proced Online 13: 1-8.
23. Donigan M, Norcross LS, Aversa J, Colon J, Smith J, et al. (2009) Novel murine model for colon cancer: non-operative trans-anal rectal injection. J Surg Res 154: 299-303.
24. Nissan A, Stojadinovic A, Mitrani-Rosenbaum S, Halle D, Grinbaum R, et al. (2012) Colon cancer associated transcript-1: a novel RNA expressed in malignant and premalignant human tissues. Int J Cancer 130: 1598-1606.
25. Dame MK, Veerapaneni I, Bhagavathula N, Naik M, Varani J, (2011) Human colon tissue in organ culture: calcium and multi-mineral-induced mucosal differentiation. In Vitro Cell Dev Biol Anim 47: 32-38.
26. Lue N, Kang JW, Yu CC, Barman I, Dingari NC, et al. (2012) Portable optical fiber probe-based spectroscopic scanner for rapid cancer diagnosis: a new tool for intraoperative margin assessment. PLoS One. 7(1): e30887. Epub 2012 Jan 27.
27. Kovar JL, Volcheck WM, Chen J, Simpson MA, (2007) Purification method directly influences effectiveness of an epidermal growth factor-coupled targeting agent for noninvasive tumor detection in mice. Anal Biochem 361: 47-54.
28. Kovar JL, Simpson MA, Schutz-Geschwender A, Olive DM, (2007) A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models. Anal Biochem 367: 1-12.
29. Italiano A, (2006) Targeting the epidermal growth factor receptor in colorectal cancer: advances and controversies. Oncology 70: 161-167.
30. Fenton JI, Hord NG, (2006) Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research. Carcinogenesis 27: 893-902.
31. Ito S, Muguruma N, Kimura T, Yano H, Imoto Y, et al. (2006) Principle and clinical usefulness of the infrared fluorescence endoscopy. J Med Invest 53: 1-8.
32. Rivera DR, Brown CM, Ouzounov DG, Pavlova I, Kobat D, et al. (2011) Compact and flexible raster scanning multiphoton endoscope capable of imaging unstained tissue. Proc Natl Acad Sci USA 108: 17598-17603.
33. Hwang DL, Lev-Ran A, (1990) Infusion of epidermal growth factor in mice: organ distribution and urinary excretion. Regul Pept 29: 103-108.
34. Kovar JL, Johnson MA, Volcheck WM, Chen J, Simpson MA, (2006) Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol 169: 1415-1426.
35. Goetz M, Ziebart A, Foersch S, Vieth M, Waldner MJ, et al. (2010) In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor. Gastroenterology 138: 435-446.
36. Li C, Wang W, Wu Q, Ke S, Houston J, et al. (2006) Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. Nucl Med Biol 33: 349-358.
37. Carpenter G, Zendegui J, (1986) Epidermal growth factor, its receptor, and related proteins. Exp Cell Res 164: l-10.
38. Saltz LB, Meropol NJ, Loehrer PJ Sr, Needle MN, Kopit J, et al. (2004) Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol 22: 1201-1208.
39. Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, et al. (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351: 337-345.
40. Moroni M, Veronese S, Benvenuti S, Marrapese G, Sartore-Bianchi A, et al. (2005) Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. Lancet Oncol 6: 279-286.
41. Francoual M, Etienne-Grimaldi MC, Formento JL, Benchimol D, Bourgeon A, et al. (2006) EGFR in colorectal cancer: more than a simple receptor. Ann Oncol 17: 962-967.
42. Funovics MA, Alencar H, Su HS, Khazaie K, Weissleder R, et al. (2003) Miniaturized multichannel near infrared endoscope for mouse imaging. Mol Imaging 2: 350-357.
43. Shao X, Zheng W, Huang Z, (2011) Near-infrared autofluorescence spectroscopy for in vivo identification of hyperplastic and adenomatous polyps in the colon. Biosens Bioelectron 30: 118-122.
44. Kamp MA, Slotty P, Turowski B, Etminan N, Steiger HJ,et al. Microscope-integrated quantitative analysis of intraoperative indocyanine green fluorescence angiography for blood flow assessment: first experience in 30 patients. Neurosurgery 70: 65-74.
45. Muguruma N, Ito S, (2008) Labeled anti-mucin antibody detectable by infrared-fluorescence endoscopy. Cancer Biomark 4: 321-328.